N.B.Medical develops medical devices to detect neurovascular disease and implement digital technologies for the healthcare sector.
N.B.Medical has raised $13.7M in total funding. The most recent round was Series B. The last funding was announced in August 2024.
N.B.Medical's investors include Mizuho Capital, ANRI, Beyond Next Ventures, JAFCO, Reazon Capital.
N.B.Medical is headquartered in Tokyo, Japan.
N.B.Medical develops medical devices to detect neurovascular disease and implement digital technologies for the healthcare sector.
N.B.Medical is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"N.B.Medical — Funding & Investors." VCBacked, August 30, 2024, https://www.vcbacked.co/company/nbmedical. Accessed November 15, 2026.
VCBacked. (2024). N.B.Medical — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/nbmedical
{{cite web |title=N.B.Medical — Funding & Investors |url=https://www.vcbacked.co/company/nbmedical |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at N.B.Medical? Request a listing update